A phase I pharmacokinetic study of the revised AP CBD/THC (Cannabidiol/tetrahydrocannabinol)

Trial Profile

A phase I pharmacokinetic study of the revised AP CBD/THC (Cannabidiol/tetrahydrocannabinol)

Planning
Phase of Trial: Phase I

Latest Information Update: 09 Mar 2018

At a glance

  • Drugs Nabiximols (Primary)
  • Indications Fibromyalgia; Pain
  • Focus Pharmacokinetics
  • Most Recent Events

    • 09 Mar 2018 According to a Intec Pharma media release, the PK trial is planned to begin in the second half of 2018.
    • 22 Nov 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top